MediPharm Labs Corp. ( MEDIF) - Key Metrics
MEDIF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.02 | $0 | $0 | $0 |
| 2026Q1 | $0.02 | $0 | $0 | $0 |
| 2025Q4 | $0.03 | $0 | $0 | $0 |
| 2025Q3 | $0.03 | -$0.01 | $0 | $0 |
| 2025Q2 | $0.03 | -$0.01 | -$0.01 | -$0.01 |
MEDIF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 1906.01 |
| 2026Q1 | 0% | -8.00 |
| 2025Q4 | 0% | -3.80 |
| 2025Q3 | 0% | -3.81 |
| 2025Q2 | 0% | -1.87 |
MEDIF
Price: $0.05
52 week price:
Earnings Per Share: -0.03 USD
P/E Ratio: -1.83
Exchange: OQB
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 22.5 million